References
- Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 2006; 103:7024 - 9; http://dx.doi.org/10.1073/pnas.0602266103; PMID: 16641092
- Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005; 102:3627 - 32; http://dx.doi.org/10.1073/pnas.0500613102; PMID: 15738415
- Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, et al. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci USA 2011; 108:4908 - 13; http://dx.doi.org/10.1073/pnas.1101795108; PMID: 21383199
- Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316:608 - 11; http://dx.doi.org/10.1126/science.1139253; PMID: 17463290
- Yao R, Ma YL, Liang W, Li HH, Ma ZJ, Yu X, et al. MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One 2012; 7:e46082; http://dx.doi.org/10.1371/journal.pone.0046082; PMID: 23091595
- Kopp KL, Ralfkiaer U, Gjerdrum LM, Helvad R, Pedersen IH, Litman T, et al. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle 2013; 12; http://dx.doi.org/10.4161/cc.24987; PMID: 23676217
- Ralfkiaer U, Hagedorn PH, Bangsgaard N, Løvendorf MB, Ahler CB, Svensson L, et al. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 2011; 118:5891 - 900; http://dx.doi.org/10.1182/blood-2011-06-358382; PMID: 21865341
- Marstrand T, Ahler CB, Ralfkiaer U, Clemmensen A, Kopp KL, Sibbesen NA, et al. Validation of a diagnostic miRNA classifier in cutaneous T-cell lymphomas. Leuk Lymphoma 2013; In press http://dx.doi.org/10.3109/10428194.2013.815352; PMID: 23772646